Intrinsic Value of S&P & Nasdaq Contact Us

NuCana plc NCNA NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • GB • USD

SharesGrow Score
50/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

NuCana plc (NCNA) has a negative trailing P/E of -0.2, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -511.92%.

Criteria proven by this page:

  • VALUE (100/100, Pass) — composite valuation score exceeds the 60/100 pass threshold.
  • Trailing Earnings Yield -511.92% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.

Overall SharesGrow Score: 49/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
50/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
90/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
MOAT
28/100
→ Income
GROWTH
15/100
→ Income
INCOME
N/A
No coverage

Valuation Snapshot — NCNA

Valuation Multiples
P/E (TTM)-0.2
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.24
P/S Ratio0.00
EV/EBITDA0.7
Per Share Data
EPS (TTM)$-7.93
Book Value / Share$6.57
Revenue / Share$0.00
FCF / Share$-2.00
Yields & Fair Value
Earnings Yield-511.92%
Dividend Yield0.00%

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -33,387.0 -2,337.09 8,001.19 0.00 -
2017 -4,226.3 -12.29 1,044.36 344,748.40 -
2018 -13,129.9 251.95 2,227.10 0.00 -
2019 -3,418.4 -58.11 1,152.26 0.00 -
2020 -2,028.4 -40.57 627.17 0.00 -
2021 -903.1 243.83 558.44 0.00 -
2022 -440.7 12.28 366.50 0.00 -
2023 -221.8 13.87 411.76 0.00 -
2024 -59.4 1.57 189.59 0.00 -
2025 -0.3 0.00 0.41 0.00 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-2.00 $0.00 $-6.05M -
2017 $-8.87 $283K $-23.09M -8157.2%
2018 $-4.25 $0.00 $-13.84M -
2019 $-6.62 $0.00 $-21.41M -
2020 $-10.12 $0.00 $-30.68M -
2021 $-9.75 $0.00 $-40.53M -
2022 $-6.12 $0.00 $-32.02M -
2023 $-5.25 $0.00 $-27.63M -
2024 $-3.27 $0.00 $-19M -
2025 $-7.75 $0.00 $-28.71M -

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-7.98 $-7.98 – $-7.98 $3.44M $3.44M – $3.44M 1
2027 $-51.88 $-51.88 – $-51.88 $8.89M $8.89M – $8.89M 1
2028 $-111.74 $-111.74 – $-111.74 $19.12M $19.12M – $19.12M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message